Pharmacologic adjunctive to insulin therapies in type 1 diabetes: The journey has just begun

DOI: 10.4239/wjd.v10.i4.234

Keywords: Type 1 diabetes, Insulin, Adjunctive therapies, Cardiovascular risk

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text